Home > Healthcare > Medical Devices > Diagnostic Devices > Legionella Testing Market
Legionella Testing Market size was valued at around USD 316.8 million in 2023 and is anticipated to register a CAGR of around 8.6% between 2024 and 2032. Legionella testing refers to the process of detecting and identifying legionella bacteria in various environments, including water systems, clinical specimens, and other potential sources of contamination.
The increasing prevalence of pneumonia and legionella-related illnesses has become a major public health concern worldwide. Legionella bacteria, especially Legionella pneumophila, can cause severe respiratory infections such as Legionnaires' disease and Pontiac fever. For instance, as per the World Health Organization (WHO), in Europe, Australia, and the U.S., an estimated 10–15 cases are detected per million population each year. Among these reported cases, individuals over 50 years old account for 75–80%, while males make up 60–70% of the affected population.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Legionella Testing Market Size in 2023: | USD 316.8 Million |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 8.6% |
2032 Value Projection: | USD 659.4 Million |
Historical Data for: | 2018 - 2023 |
No. of Pages: | 201 |
Tables, Charts & Figures: | 339 |
Segments covered: | Test Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Furthermore, governments and regulatory bodies around the world have implemented stringent regulations and guidelines for regular water testing, especially in high-risk environments such as healthcare facilities, hotels, nursing homes, and industrial settings. These regulations mandate the implementation of comprehensive water management plans, including routine legionella testing, to mitigate the risk of legionella contamination and protect public health.